| |MAY 20248SUN PHARMA ACCOUNTS NET PROFIT OF 2,654.58 CRORE IN Q4WHO NODS 33 NATIONAL & REGIONAL REGULATORY AUTHORITIES FOR MEDICAL PRODUCTSSun Pharmaceutical Industries Ltd revealed a united net profit of 2,654.58 crore in the final quarter ended on March 31, 2024. The organization had posted a merged net benefit of 1,984.47 crore in the final quarter of the past fiscal, Sun Pharmaceutical Industries said in an administrative document.During the period under review, the total revenue from operations was 11,982.9 crore. It also stated that it stood at 10,930.67 crore during the same quarter a year ago. In the fourth quarter, formulation sales in India totaled 3,707.8 crore, while formulation sales in the United States totaled $ 476 million, or roughly 3,964 crore.The pharmaceutical firm said the outcomes for the quarter ended on December 31, 2023, and the quarter and the year ended on March 31, 2024, are not similar with different periods because of the acquisition of 60percent shareholding in Vivaldis Wellbeing and Food Pvt Ltd which was finished during the quarter ended June 30, 2023.The board has suggested a final dividend of Rs 5 for equity share of Re 1 each dependent upon endorsement by investors at the following yearly comprehensive gathering, the organization said. It added that this is on top of the interim dividend that was paid out in FY24, which was 8.5 per share. This brings the total dividend for FY24 to 13.5 per share, compared to 11.5 per share for FY23. POWHO has accepted the designation of 33 national and regional regulatory agencies as WHO Listed agencies (WLAs), which can be depended on to meet the highest level of regulatory standards and practices for the quality, safety, and efficacy of drugs and vaccines. This listing brings the overall number of regulatory authorities from 34 Member States recognized as WLAs to 36 since the initiative's start in March 2022.The European Medicines Agency (EMA), the European Commission, the European Medicines Agency (BLA), and the medicine regulatory bodies of the following 30 nations comprise the newly approved WLAs: Germany (Paul-Ehrlich-Institut & Federal Institute for Drugs and Medical Devices), Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain and Sweden."Today marks a significant progress in our collective efforts to improve access to safe, quality and effective medicines and vaccines. With leading regulatory authorities joining our list, we are stronger and more united to improve access to quality, safe and effective medicines and vaccines for millions more people," said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. "I would like to congratulate all agencies designated as WLAs for their investment and commitment to the quality and safety of medicines and vaccines. My thanks also to our experts for their diligent work to implement a transparent and evidence-based assessment throughout the evaluation process". POTOP STORIES
< Page 7 | Page 9 >